NAFLD leads to liver cancer: Do we have sufficient evidence?

被引:91
作者
Duan, Xiao-Yan [1 ]
Zhang, Lei [2 ]
Fan, Jian-Gao [1 ]
Qiao, Liang [3 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Key Lab Childrens Digest & Nutr, Dept Gastroenterol, Xinhua Hosp,Sch Med, Shanghai 200092, Peoples R China
[2] Lanzhou Univ, Hosp 1, Dept Gen Surg, Lanzhou 730000, Gansu, Peoples R China
[3] Westmead Millennium Inst, Univ Sydney, Storr Liver Unit, Westmead, NSW 2145, Australia
基金
澳大利亚国家健康与医学研究理事会; 中国国家自然科学基金;
关键词
Fatty liver; Nonalcoholic steatohepatitis; Liver cancer; Hepatocellular carcinoma; NONALCOHOLIC FATTY LIVER; TERM-FOLLOW-UP; HEPATOCELLULAR-CARCINOMA; NATURAL-HISTORY; RISK-FACTORS; DIABETES-MELLITUS; CRYPTOGENIC CIRRHOSIS; METABOLIC SYNDROME; CLINICAL-FEATURES; IRON OVERLOAD;
D O I
10.1016/j.canlet.2013.07.033
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Primary liver cancer has several well-recognized risk factors, such as HBV and HCV infection, alcohol abuse and aflatoxin. Recent studies show that nonalcoholic fatty liver disease (NAFLD), especially its aggressive form nonalcoholic steatohepatitis (NASH) is associated with an increased risk of liver cancer, mainly hepatocellular carcinoma (HCC). On the other hand, clinical and epidemiological data have showed that HCC has rarely been found in a "pure" fatty liver in human. Thus, the question we need to ask is do we have sufficient evidence to support a causative role of NAFLD in liver cancer? Furthermore, if NAFLD is indeed a causative factor for liver cancer, what is the mechanism? Perhaps at this stage, fatty liver and NASH can be regarded as a definite risk factor for liver cancer, but to conclude that NAFLD induces HCC requires more robust in vitro and in vivo data. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:230 / 234
页数:5
相关论文
共 87 条
[1]
Abergel Armand, 2006, Rev Prat, V56, P2130
[2]
The natural history of nonalcoholic fatty liver disease: A population-based cohort study [J].
Adams, LA ;
Lymp, JF ;
St Sauver, J ;
Sanderson, SO ;
Lindor, KD ;
Feldstein, A ;
Angulo, P .
GASTROENTEROLOGY, 2005, 129 (01) :113-121
[3]
The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies [J].
Adams, LA ;
Sanderson, S ;
Lindor, KD ;
Angulo, P .
JOURNAL OF HEPATOLOGY, 2005, 42 (01) :132-138
[4]
Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: A clinical and pathological study [J].
Alexander, Jacob ;
Torbenson, Michael ;
Wu, Tsung-Teh ;
Yeh, Matthew M. .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (05) :848-854
[5]
The Incidence and Risk Factors of Hepatocellular Carcinoma in Patients with Nonalcoholic Steatohepatitis [J].
Ascha, Mustafa S. ;
Hanouneh, Ibrahim A. ;
Lopez, Rocio ;
Tamimi, Tarek Abu-Rajab ;
Feldstein, Ariel F. ;
Zein, Nizar N. .
HEPATOLOGY, 2010, 51 (06) :1972-1978
[6]
Iron Deprivation Suppresses Hepatocellular Carcinoma Growth in Experimental Studies [J].
Ba, Qian ;
Hao, Miao ;
Huang, He ;
Hou, Junmei ;
Ge, Shichao ;
Zhang, Zhuzhen ;
Yin, Jun ;
Chu, Ruiai ;
Jiang, Hualiang ;
Wang, Fudi ;
Chen, Kaixian ;
Liu, Hong ;
Wang, Hui .
CLINICAL CANCER RESEARCH, 2011, 17 (24) :7625-7633
[7]
Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace [J].
Baffy, Gyoergy ;
Brunt, Elizabeth M. ;
Caldwell, Stephen H. .
JOURNAL OF HEPATOLOGY, 2012, 56 (06) :1384-1391
[8]
Hepatocellular carcinoma without cirrhosis in a patient with nonalcoholic steatohepatitis [J].
Bencheqroun, R ;
Duvoux, C ;
Luciani, A ;
Zafrani, ES ;
Dhumeaux, D .
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2004, 28 (05) :497-499
[9]
Bhala N., 2013, CURR PHARM DES, V4
[10]
Non-viral causes of hepatocellular carcinoma [J].
Blonski, Wojciech ;
Kotlyar, David S. ;
Forde, Kimberly A. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (29) :3603-3615